Jove
Visualize
お問い合わせ

関連する概念動画

Lysosomes01:31

Lysosomes

27.3K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
27.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

5.7K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.7K
Glucose Transporters01:27

Glucose Transporters

28.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.4K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

7.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.1K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

HKDC1 contributes to aberrant lysosome-mitochondria contact in Niemann-Pick disease type C.

bioRxiv : the preprint server for biology·2026
Same author

Erratum to "Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids" [Pharmacological Reviews 78 (2026) 100113].

Pharmacological reviews·2026
Same author

Synthesis of N-Acetyl-D- and -L-Leucine-<sup>13</sup>C<sub>6</sub> Tool Compounds in Neurodegenerative Disease.

ChemMedChem·2026
Same author

Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids.

Pharmacological reviews·2026
Same author

Molecular and biochemical insights into dysregulation of glycosphingolipid metabolism in a mouse model of lysosomal free sialic acid storage disorder.

Experimental neurology·2026
Same author

Limited therapeutic efficacy of N-acetyl-L-leucine in a mouse model of CLN1 disease.

Scientific reports·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Apr 15, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.7K

スフィンゴリピドのリソソーム性貯蔵障害

Frances M Platt1

  • 1Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK.

Nature
|June 6, 2014
PubMed
まとめ
この要約は機械生成です。

リソソーム貯蔵病は,マクロ分子蓄積によって引き起こされる遺伝的代謝障害です. これらの珍しい状態,特にグリコスフィンゴリピドの貯蔵に関する研究は,細胞生物学と治療の開発を進めています.

さらに関連する動画

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis
09:09

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis

Published on: April 27, 2021

2.7K
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

4.1K

関連する実験動画

Last Updated: Apr 15, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.7K
Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis
09:09

Preparation of Human Tissues Embedded in Optimal Cutting Temperature Compound for Mass Spectrometry Analysis

Published on: April 27, 2021

2.7K
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

4.1K

科学分野:

  • バイオケミストリー バイオケミストリー
  • 遺伝学 遺伝学とは
  • 細胞生物学 細胞生物学

背景:

  • リソソーム貯蔵疾患 (LSD) は,代謝の先天的な誤りであり,末期の内細胞系におけるマクロ分子蓄積によって特徴付けられます.
  • これらの単一性疾患は,5000生児の1人に集団的に発生し,リゾソームタンパク質,主に酵素をコードする遺伝子の遺伝的欠陥に起因する.
  • 特定のサブセットは,グリコスフィンゴリピドのリゾソーム性貯蔵を含む.

研究 の 目的:

  • スフィンゴリピド貯蔵障害の研究を通じて,細胞生物学の基本的側面を解明する.
  • リソソーム貯蔵疾患における治療的進歩を強調する.
  • LSDと一般的な疾患との間の新たなつながりを探求する.

主な方法:

  • モノジェニック疾患の遺伝子分析.
  • 代謝経路の生化学的調査.
  • 末期の内細胞系に焦点を当てた細胞研究.

主要な成果:

  • スフィンゴリピド貯蔵障害の理解は,基本的な細胞生物学に対する重要な洞察をもたらしました.
  • LSDの治療法を開発するうえで大きな進展がみられ,現在,臨床で使用されている治療法がいくつかあります.
  • LSDとより一般的な疾患との間の新しいメカニズム的な関連が明らかにされています.

結論:

  • リソソーム貯蔵疾患の研究は,基本的な細胞生物学と疾患メカニズムに関する深い洞察を提供します.
  • LSDの治療戦略はかなり進歩し,患者の治療結果を改善しています.
  • 珍しい遺伝疾患と一般的な疾患の間の境界線は,共通の根本的なメカニズムのために再評価する必要があるかもしれません.